Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.45 -0.03 (-0.86%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bolt Biotherapeutics (BOLT) Return on Equity [ROE] (2021 - 2026)

Updated

Bolt Biotherapeutics' Return on Equity [ROE] came in at -181.54% for Q2 2026, down 62.95 percentage points from -118.58% a year earlier and down 52.54 percentage points from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Bolt Biotherapeutics' Return on Equity [ROE] was -80.32%, down 0.54 percentage points from FY2024.

  • Return on Equity [ROE] has declined in each of the last three years, though with a four-year change of +47.12 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Equity [ROE] was -79.79% in FY2024 (-31.10 pp), -48.69% in FY2023 (-6.90 pp), -41.79% in FY2022 (+85.65 pp) and -127.44% in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q1 2021.
  • Year-over-year, Return on Equity [ROE] has declined for 17 consecutive quarters, with an average year-over-year change of -37.36 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2022 (a gain of 18.34 percentage points), and the weakest in Q2 2026 (a drop of 62.95 percentage points).
  • Business Quant data shows BOLT's Return on Equity [ROE] at -129.00% (Q1 2026), -114.72% (Q4 2025) and -120.76% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Bolt Biotherapeutics 6.65 Mn 6.65 Mn - -181.54%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -181.54%
Mar 31, 2026 -129.00%
Dec 31, 2025 -114.72%
Sep 30, 2025 -120.76%
Jun 30, 2025 -118.58%
Mar 31, 2025 -121.85%
Dec 31, 2024 -104.92%
Sep 30, 2024 -88.36%
Jun 30, 2024 -74.56%
Mar 31, 2024 -62.43%
Dec 31, 2023 -57.42%
Sep 30, 2023 -52.73%
Jun 30, 2023 -51.23%
Mar 31, 2023 -49.45%
Dec 31, 2022 -48.95%
Sep 30, 2022 -48.06%
Jun 30, 2022 -44.41%
Mar 31, 2022 -40.88%
Dec 31, 2021 -35.24%
Sep 30, 2021 -28.82%
API Access

Bolt Biotherapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BOLT&period=max&api_key=YOUR_API_KEY